Custom Multi-Component Veterinary Drug Reference Standards (Amphenicols, Avermectins, Nitroimidazoles, Quinolones, Fluoroquinolones)

The contract calls for the production of ISO 17034-certified reference standards targeting multiple veterinary drug classes, including chloramphenicol, ivermectin, metronidazole, and enrofloxacin, encompassing amphenicols, avermectins, nitroimidazoles, and fluoroquinolones. Each class will be delivered in two certified lots, designated as ICV and CCV, with each lot consisting of five 1mL ampules, ensuring consistent, traceable, and analytically validated materials for regulatory and laboratory use. Full analytical documentation must accompany each batch, confirming identity, purity, concentration, and stability in accordance with international metrological standards for reference materials. The work is to be performed at a facility located in Denver, Colorado, with a strict submission deadline of August 7, 2026, and is issued under a subcontract arrangement by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The North American Industry Classification System code 325412 confirms the manufacturing focus on pharmaceutical preparations, emphasizing the technical and regulatory rigor expected from the vendor to meet federal standards for reference standards used in veterinary drug testing and compliance monitoring.